SILC DATA SOURCES
The commercial legacy system SILC still falls back to for launch dates — the one it's replacing as the single source of truth
Ignite
The US agency that approves new medicines before they can be sold
FDA (Food and Drug Administration)
Elapsed time from when work starts on an item to when it's done
Cycle time
Strategic plan for how a product is positioned, messaged, priced and promoted across its lifecycle
Brand Plan
Platform Marion uses to announce onboarding is live
Yammer
The new external source SILC is plugging in so Launch Teams get real vaccines commercial launch dates straight in the platform — later feeding Navigator's TPP/TVP data too
iPort
An influential expert whose views shape how other doctors treat a disease. In a launch, pharma companies engage them through Medical Affairs to help build clinical awareness and confidence before and around approval. Ex: a leading oncologist who speaks at congresses and authors treatment guidelines.
KOLs : Key Opinion Leaders
How long an in-progress item has been active but not yet finished
Work Item Age (Aging WIP)
Function between R&D and Commercial — communicates scientific evidence, engages KOLs, non-promotionally
Medical Affairs
The cloud "data warehouse" where all SILC data lives and analysts run their queries
Snowflake
The corporate (IBM) financial-planning system SILC connects to so Mission Control and Portfolio show forecast and peak-sales numbers users can trust
TM1
Evidence from routine clinical practice, not controlled trials
RWE (Real-World Evidence)
Number of work items finished per unit of time (per week, per sprint) — a measure of delivery rate
Throughput
Function ensuring a product is available, affordable and reimbursed — secures coverage from health systems
Market Access
The design tool where SILC's screens are drawn (by Jenn & Laura) before any code is written
Figma
(powered with AI it's "Prototyper" - widget developed by Sanofi - available in cursor)
The life-sciences cloud that runs much of pharma's regulatory work — SILC is exploring connecting its "Reg" module as a new source of actual approval data (actual submission and actual approval)
Veeva RIM
A single unit that combines how long a treatment lets someone live with how well they live during that time. It's the standard measure health economists use to judge whether a drug is worth its cost.
QALY — Quality-Adjusted Life Year
A forecasting method that uses past throughput to answer "when will it be done?"
Montecarlo Simulation
Insurers or government bodies that decide whether to cover and pay for a medicine
Payers
Tool that records real user sessions — heatmaps, clicks, scrolls — to reveal how people actually use the app
Mouseflow
Sanofi's global R&D project-management system — the 'system of record' SILC pulls planned milestone dates (submission, approval) from.
RDPM (Research & Development Project Management) now called P360 (for portfolio 360)
The discipline that proves a drug is worth its price — not just that it works clinically, but that it delivers value for the money spent. HEOR teams generate the economic and real-world evidence (cost per QALY, budget impact, patient outcomes) that Market Access uses to convince payers and HTA bodies to cover and reimburse the product.
HEOR — Health Economics and Outcomes Research
The four measures of software-delivery performance every dev team should track — deploy frequency, lead time, change-failure rate, time-to-restore
Monitoring a drug's safety once it's on the market
PV (Pharmacovigilance)
The platform SILC uses to track and evaluate its AI models and the SILC Agent's LLM answers
Weave from Weights & Biases